2-178713381-TACAAAACAAAACAAA-TACAAAACAAAACAAAACAAAACAAAACAAAACAAAACAAA

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1

The NM_001267550.2(TTN):​c.26762-34_26762-10dupTTTGTTTTGTTTTGTTTTGTTTTGT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0107 in 1,468,192 control chromosomes in the GnomAD database, including 584 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.014 ( 83 hom., cov: 24)
Exomes 𝑓: 0.010 ( 501 hom. )

Consequence

TTN
NM_001267550.2 intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:7

Conservation

PhyloP100: 1.08

Publications

4 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 2-178713381-T-TACAAAACAAAACAAAACAAAACAAA is Benign according to our data. Variant chr2-178713381-T-TACAAAACAAAACAAAACAAAACAAA is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 96274.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.152 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.26762-34_26762-10dupTTTGTTTTGTTTTGTTTTGTTTTGT intron_variant Intron 92 of 362 ENST00000589042.5 NP_001254479.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.26762-10_26762-9insTTTGTTTTGTTTTGTTTTGTTTTGT intron_variant Intron 92 of 362 5 NM_001267550.2 ENSP00000467141.1

Frequencies

GnomAD3 genomes
AF:
0.0143
AC:
2151
AN:
150874
Hom.:
84
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00225
Gnomad AMI
AF:
0.00664
Gnomad AMR
AF:
0.0112
Gnomad ASJ
AF:
0.0173
Gnomad EAS
AF:
0.161
Gnomad SAS
AF:
0.00929
Gnomad FIN
AF:
0.0368
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00811
Gnomad OTH
AF:
0.0125
GnomAD2 exomes
AF:
0.0229
AC:
2300
AN:
100440
AF XY:
0.0222
show subpopulations
Gnomad AFR exome
AF:
0.00222
Gnomad AMR exome
AF:
0.0131
Gnomad ASJ exome
AF:
0.00839
Gnomad EAS exome
AF:
0.168
Gnomad FIN exome
AF:
0.0312
Gnomad NFE exome
AF:
0.00491
Gnomad OTH exome
AF:
0.0128
GnomAD4 exome
AF:
0.0103
AC:
13514
AN:
1317202
Hom.:
501
Cov.:
33
AF XY:
0.0101
AC XY:
6497
AN XY:
641532
show subpopulations
African (AFR)
AF:
0.00154
AC:
44
AN:
28586
American (AMR)
AF:
0.0113
AC:
249
AN:
22036
Ashkenazi Jewish (ASJ)
AF:
0.0121
AC:
256
AN:
21164
East Asian (EAS)
AF:
0.146
AC:
4991
AN:
34256
South Asian (SAS)
AF:
0.00540
AC:
337
AN:
62440
European-Finnish (FIN)
AF:
0.0359
AC:
1682
AN:
46836
Middle Eastern (MID)
AF:
0.00399
AC:
16
AN:
4006
European-Non Finnish (NFE)
AF:
0.00506
AC:
5284
AN:
1043628
Other (OTH)
AF:
0.0121
AC:
655
AN:
54250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
492
984
1477
1969
2461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
252
504
756
1008
1260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0142
AC:
2145
AN:
150990
Hom.:
83
Cov.:
24
AF XY:
0.0159
AC XY:
1169
AN XY:
73694
show subpopulations
African (AFR)
AF:
0.00224
AC:
92
AN:
41026
American (AMR)
AF:
0.0112
AC:
170
AN:
15154
Ashkenazi Jewish (ASJ)
AF:
0.0173
AC:
60
AN:
3468
East Asian (EAS)
AF:
0.161
AC:
815
AN:
5048
South Asian (SAS)
AF:
0.00887
AC:
42
AN:
4734
European-Finnish (FIN)
AF:
0.0368
AC:
385
AN:
10470
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.00811
AC:
550
AN:
67796
Other (OTH)
AF:
0.0114
AC:
24
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
92
184
276
368
460
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00523
Hom.:
211

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:7Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jul 23, 2013
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

May 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:3
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jan 11, 2020
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 23, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

c.23030-39_23030-35[11] in intron 89 of TTN: This variant is part of a 5 bp repe at (TTTGT) and adds 5 repeat units to 6 present in the reference sequence. It is not expected to have clinical significance because it has been identified in 13 .5% (73/540) of East Asian chromosomes and 4.2% (70/1672) of Finnish chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org).

Limb-girdle muscular dystrophy, recessive Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Early-onset myopathy with fatal cardiomyopathy Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dilated Cardiomyopathy, Dominant Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Myopathy, myofibrillar, 9, with early respiratory failure Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Tibial muscular dystrophy Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hypertrophic cardiomyopathy Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TTN-related disorder Benign:1
Aug 07, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71393436; hg19: chr2-179578108; API